Friday, July 10, 2026

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,798
Companies 1,771
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,798 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 19 of 200 · By data quality, then INN

  1. glycopyrrolate

    GLYCOPYRROLATE Regeneron Ireland Designated Activity Company (DAC)

    ORAL FDA: approved

  2. golodirsen

    VYONDYS 53 Sarepta Therapeutics

    INTRAVENOUS FDA: approved

  3. granisetron

    SANCUSO Heron Therapeutics

    SUBCUTANEOUS FDA: approved · EMA: approved

    A04AA02
  4. granisetron hydrochloride

    GRANISETRON HYDROCHLORIDE Amneal Pharma Europe Ltd

    INJECTION FDA: approved

  5. guaifenesin

    GUAIFENESIN Amneal Pharma Europe Ltd

    ORAL FDA: approved

  6. guanfacine

    INTUNIV Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    C02AC02
  7. guanfacine hydrochloride

    INTUNIV PARTIAL CHANGE APPROVAL Amneal Pharma Europe Ltd

    ORAL FDA: approved · PMDA: approved

  8. haloperidol

    HALOPERIDOL MEDSURGE Lacuna Pharma Pty Ltd

    INJECTION FDA: approved · TGA: approved

  9. haloperidol decanoate

    HALDOL DECANOATE Teva Pharma GmbH

    INJECTION FDA: approved · TGA: approved

  10. haloperidol lactate

    HALOPERIDOL Teva Pharma GmbH

    INJECTION FDA: approved

  11. heparin sodium

    HEPARIN SODIUM CASI Pharmaceuticals

    INJECTION FDA: approved

  12. hexachlorophene

    SOY-DOME ADIAL PHARMACEUTICALS, INC.

    TOPICAL FDA: approved

  13. homatropine methylbromide

    HOMAPIN-10 Teva Pharma GmbH

    ORAL FDA: approved

  14. human fibrinogen

    TACHOSIL S.A.

    EMA: approved

    B02BC30
  15. human igg1 monoclonal antibody specific for human interleukin-1 alpha

    HUMAN IGG1 MONOCLONAL ANTIBODY SPECIFIC FOR HUMAN INTERLEUKIN-1 ALPHA XBIOTECH XBiotech Germany GmbH

    EMA: refused

    L01
  16. human normal immunoglobulin

    HYQVIA Takeda

    EMA: approved

    J06BA01
  17. human protein c

    CEPROTIN Takeda

    EMA: approved

    B01AD12
  18. hyaluronidase

    VITRAGAN Amphastar France Pharmaceuticals

    INJECTION FDA: approved · EMA: application withdrawn

  19. hyaluronidase recombinant human

    HYLENEX RECOMBINANT HALOZYME THERAPEUTICS, INC.

    INJECTION FDA: approved

  20. hydralazine hydrochloride

    HYDRALAZINE HYDROCHLORIDE Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  21. hydrochlorothiazide

    DITHIAZIDE Amneal Pharma Europe Ltd

    ORAL FDA: approved · TGA: approved

  22. hydrocodone bitartrate

    HYDROCODONE BITARTRATE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  23. hydrocortisone

    HYDROCORTISONE VIATRIS 20 Alphapharm Pty Ltd

    FOR RX COMPOUNDING FDA: approved · EMA: approved · TGA: approved

    H02AB09
  24. hydrocortisone butyrate

    HYDROCORTISONE BUTYRATE Chongqing Precision Biotech Co., Ltd

    TOPICAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,798 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.